Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
Study NCT ID:
NCT06714708
Status:
RECRUITING
Last Update Posted:
2025-02-10
First Post:
2024-11-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
Sponsor:
Anhui Provincial Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-20
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-27
First Submit QC Date:
None
Study First Post Date:
2024-12-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-06
Last Update Post Date:
2025-02-10
Last Update Post Date Type:
ACTUAL